Chemical synthesis method of solasonine and derivatives thereof

Through the synergistic catalytic glycosylation method of gold (III)-nitrile and the cyanogenic effect of benzoyl cyanide, the efficient synthesis of Australian solanine and its derivatives is achieved, solving the problem of preparation difficulties in the prior art and improving the synthesis efficiency and yield, suitable for industrial production.

CN118978562AActive Publication Date: 2024-11-19SHANDONG UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411041803.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-19
Estimated Expiration
2044-07-31

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently synthesize alanine and its derivatives, especially due to its low content and structural complexity in plants, and its enzymatic synthesis efficiency is low. The existing methods require complex protection and deprotection. Operation leads to inefficient synthesis.

Method used

The method of synergistic catalytic glycosylation of gold (III)-nitrile is adopted to achieve efficient synthesis of ashelline and its derivatives through efficient selective linkage between glycosyl donor and aglycone acceptor, and the cyanogenic effect of benzoyl cyanide is used. Perform selective protection to avoid tedious protection and de-protection operations.

Benefits of technology

It has achieved efficient and simple synthesis of alanine and its derivatives, overcomes the cumbersomeness of protection and deprotection operations in traditional methods, improves yield and synthesis efficiency, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978562A_ABST
    Figure CN118978562A_ABST
Patent Text Reader

Abstract

The invention discloses a chemical synthesis method of solasonine and derivatives thereof, and belongs to the field of sugar chemistry. The method for preparing the compound shown in the formula I comprises the following steps: performing glycosylation reaction on a compound 4 and a compound 3 or 5 under the synergistic catalysis of gold (III) ions and nitrile compounds to obtain a compound 16 or 15; and a step of deprotection, in the # imgabs0 #, X is-NH <-> or-O <->; wherein the structures of the compounds 3, 4, 5, 15 and 16 are as follows: # imgabs1 # and # imgabs2 #. The invention establishes a glycosylation method for synergistically catalyzing gold (III) ions and nitrile compounds, the compound 4 and the compound 3 or the compound 5 are subjected to efficient glycosylation, and the compound 16 or the compound 15 with beta configuration is obtained with high yield.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of carbohydrate chemistry, and in particular relates to an efficient and simple convergent chemical synthesis method for synthesizing solanine and its derivatives. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Glycoalkaloids are secondary metabolites found in Solanaceae plants such as potatoes, potatoes, and eggplants. They are mainly used to protect the plants themselves from pathogens and predators. They have a variety of pharmacological effects, such as antibiotic, antifungal, antibacterial and antiviral properties. Among them, solanine is a typical spirostane-type glycoalkaloid isolated from Solanum plants, consisting of a hydrophilic sugar chain (solanose triose) and a hydrophobic aglycone (solanose amine). Solanose triose includes β-D-galactose, β-D-glucose and α-L-rhamnose. Solanose amine has a steroidal skeleton of 27 carbon atoms, and the only heteroatom is the nitrogen atom at the C-26 position. Studies have shown that solanine has very important ecological significance for plants, such as inhibiting the growth of the pest red powder beetle, having allelopathic effects, and can inhibit the growth of larvae of other plants except Solanum plants. Solanine also exhibits strong physiological activities, such as inhibiting the proliferation of tumor cells, antifungal, and anticancer. Recently, researchers have found that solanine can induce ferroptosis and kill tumor cells. Although solanine has potential biological significance, current research on its activity and mechanism still relies on extraction and separation from natural products. The content of glycoalkaloids in plants is relatively low, and the content of solanine is only 1%. The similar structure of glycoalkaloids also brings certain difficulties to separation and purification. Therefore, how to prepare glycoalkaloids of a single configuration efficiently and in high yield has become a key task for researchers. Due to the specificity of the substrate and the lack of enzymes, enzymatic synthesis cannot be an effective approach. However, chemical synthesis has the characteristics of flexibility and variability, making it a powerful means. In recent decades, researchers have made great efforts in the synthesis of steroidal glycoalkaloids, but the effective construction of compounds containing glycosylation structures at position 2 is still a major synthetic obstacle. Linear synthesis of the β-glycosidic bond at position 2 usually requires the use of a temporary acyl protecting group at position 2, which requires selective protection and deprotection operations of the protecting group.

[0004] Although researchers have explored a variety of strategies, including remote participation, intramolecular glycosyl delivery (IAD), and helium-bond directed glycosyl delivery (HAD), in order to improve the stereoselectivity of the synthesis, these methods all introduce complex protection and deprotection group operations, which seriously restrict the overall efficiency of the synthesis process. Therefore, to date, there is no technology that can achieve efficient and large-scale preparation of solanine and its derivatives. This situation highlights the limitations of the current synthesis method and makes the efficient preparation of solanine and its derivatives a synthetic problem. Summary of the invention

[0005] In order to solve the deficiencies of the prior art, the purpose of the present invention is to provide a chemical synthesis method of solanine and its derivatives. The chemical synthesis method provided by the present invention is efficient and simple.

[0006] In order to achieve the above object, the technical solution of the present invention is:

[0007] The first aspect of the present invention provides a method for preparing a compound of formula I.

[0008]

[0009] Wherein, X is -NH- or -O-;

[0010] The method comprises the steps of glycosidation reaction of compound 4 and compound 3 or 5 under the coordinated catalysis of gold (III) ions and nitrile compounds to obtain compound 16 or 15; and a deprotection step;

[0011] Among them, the structures of compounds 3, 4, 5, 15 and 16 are shown below:

[0012]

[0013] When X is -NH-, the compound shown in formula I is solanine; when X is O, the compound shown in formula I is a natural derivative of solanine.

[0014] The natural derivative of solanine prepared by the present invention is also extracted from Solanum genus plants and is divided into two parts: solanose and diosgenin. Research on its derivatives is helpful to deeply understand the mechanism of action and biological activity of solanine and its derivatives.

[0015] The invention provides a gold (III)-nitrile coordinated catalytic glycosidation glycosylation method to achieve efficient and selective connection between a glycosyl donor and aglycone, and can catalyze donors without adjacent group participation or remote group participation.

[0016] In some embodiments of the present invention, when compound 4 is subjected to glycosidation reaction with compound 3, the method further comprises: before deprotection, reducing the azide group in compound 16 to an amino group.

[0017] In some embodiments of the present invention, the nitrile compound is trimethylacetonitrile.

[0018] In some embodiments of the present invention, the preparation method of compound 4 comprises the following steps:

[0019] Compound 6 and compound 7 are subjected to glycosylation reaction to obtain compound 13;

[0020] Converting compound 13 into compound S1;

[0021] Converting compound S1 into compound 4;

[0022] Among them, the structures of compounds 6, 7, 13 and S1 are shown below:

[0023]

[0024] In some embodiments of the present invention, the conversion of compound 13 into compound S1 comprises the following steps:

[0025] Compound 13 was dissolved in a mixed solution of acetonitrile and water, and ammonium cerium nitrate was added at low temperature to react. After the reaction was completed, compound S1 was obtained.

[0026] Preferably, the low temperature is -2 to 2°C.

[0027] In some embodiments of the present invention, the conversion of compound S1 into compound 4 comprises the following steps:

[0028] Compound S1 was dissolved in an organic solvent, and trichloroacetonitrile and 1,8-diazabicyclo[5.4.0]undec-7-ene were added in sequence under an ice-water bath. The temperature was naturally raised to react. After the reaction was completed, compound 4 was obtained.

[0029] Preferably, the organic solvent comprises dichloromethane.

[0030] In some embodiments of the present invention, the preparation method of compound 7 comprises the following steps:

[0031] Converting compound 10 into compound 9;

[0032] Compound 9 is subjected to glycosylation reaction with compound 8 to obtain compound 11;

[0033] Converting compound 11 into compound 12;

[0034] An acylating agent was used to selectively protect the 4- and 6-hydroxyl groups in compound 12 to obtain compound 7;

[0035] Among them, the structures of compounds 8, 9, 10, 11 and 12 are shown below:

[0036]

[0037] In some embodiments of the present invention, the conversion of compound 10 into compound 9 comprises the following steps:

[0038] Compound 10 was dissolved in an organic solvent, 2,6-lutidine was added under a protective atmosphere, and after stirring at low temperature, tert-butyldimethylsilyl trifluoromethanesulfonate was added and stirred for reaction. After the reaction was completed, compound 9 was obtained.

[0039] Preferably, the organic solvent comprises N,N-dimethylformamide.

[0040] Preferably, the low temperature is -55 to -45°C.

[0041] In some embodiments of the present invention, the conversion of compound 11 into compound 12 of formula comprises the following steps:

[0042] Tetrabutylammonium fluoride solution was added to compound 11, and the mixture was stirred at room temperature to react. After the reaction was completed, compound 12 was obtained.

[0043] Preferably, in the tetrabutylammonium fluoride solution, the solvent is tetrahydrofuran.

[0044] In some embodiments of the present invention, the acylating agent is benzoyl chloride;

[0045] Using the cyanide effect of benzoyl cyanide, compound 12 was reacted in a one-pot reaction at low temperature to obtain compound 7 with selective protection at the 4 and 6 positions.

[0046] Preferably, the low temperature is -80 to -75°C.

[0047] The invention uses a regioselective benzoylation system using benzoyl cyanide as an acylating agent to perform selective protection, thereby avoiding cumbersome protection and deprotection operations.

[0048] The beneficial effects of the present invention are:

[0049] The present invention provides an efficient and simple convergent synthesis route for the sugar alkaloid solanine and its derivatives. On the one hand, the present invention utilizes the cyanide effect of benzoyl cyanide to obtain the disaccharide receptor compound 7 with selective protection at the 4,6 positions in one pot at -78°C with a yield of 80%, overcoming the time-consuming protection and deprotection operations; on the other hand, the present invention also establishes a new synergistic catalytic glycosylation method using gold trichloride as a catalyst and trimethylacetonitrile as a ligand, and efficiently glycosylates the glycosyl donor 4 with the aglycone receptor 3 or the aglycone receptor 5, and obtains the β-configuration compound 16 or compound 15 with a high yield.

[0050] The method for synthesizing alkali solanine and its derivatives of the invention is simple to operate, has readily available raw materials, is highly practical, has a high yield and low cost, and is of great significance for the industrial production of such substances. BRIEF DESCRIPTION OF THE DRAWINGS

[0051] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

[0052] Figure 1 The NMR of compound 9 prepared in Example 1 of the present invention is 1 H spectrum;

[0053] Figure 2 The NMR of compound 11 prepared in Example 1 of the present invention 1 H spectrum;

[0054] Figure 3 The NMR of compound 11 prepared in Example 1 of the present invention 13 C spectrum;

[0055] Figure 4 The NMR of compound 12 prepared in Example 1 of the present invention 1 H spectrum;

[0056] Figure 5 The NMR of compound 12 prepared in Example 1 of the present invention 13 C spectrum;

[0057] Figure 6 The NMR of compound 7 prepared in Example 1 of the present invention is 1 H spectrum;

[0058] Figure 7 The NMR of compound 7 prepared in Example 1 of the present invention is 13 C spectrum;

[0059] Figure 8 The NMR of compound 13 prepared in Example 2 of the present invention 1 H spectrum;

[0060] Fig. 9 The NMR of compound 13 prepared in Example 2 of the present invention 13 C spectrum;

[0061] Fig.10 The NMR of compound 4 prepared in Example 2 of the present invention 1 H spectrum;

[0062] Fig.11 The NMR of compound 4 prepared in Example 2 of the present invention 13 C spectrum;

[0063] Fig.12 The NMR of compound 16 prepared in Example 3 of the present invention 1 H spectrum;

[0064] Fig.13 The NMR of compound 16 prepared in Example 3 of the present invention 13 C spectrum;

[0065] Fig.14 The NMR of compound 17 prepared in Example 3 of the present invention 1 H spectrum;

[0066] Fig.15 The NMR of compound 17 prepared in Example 3 of the present invention 13 C spectrum;

[0067] Fig.16 The NMR of compound 1 prepared in Example 3 of the present invention is 1 H spectrum;

[0068] Fig.17 The NMR of compound 1 prepared in Example 3 of the present invention is 13 C spectrum;

[0069] Fig.18 The NMR of compound 15 prepared in Example 4 of the present invention 1 H spectrum;

[0070] Fig.19 The NMR of compound 15 prepared in Example 4 of the present invention 13 C spectrum;

[0071] Fig. 20 The NMR of compound 2 prepared in Example 4 of the present invention 1 H spectrum;

[0072] Fig.21 The NMR of compound 2 prepared in Example 4 of the present invention 13 C spectrum. DETAILED DESCRIPTION

[0073] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.

[0074] The raw materials and reagents used in the following examples are all conventional commercially available products and can be purchased.

[0075] Example 1

[0076] 1.1 Chemical synthesis of 4-methoxyphenyl 2-O-(2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl)-4,6-di-O-benzoyl-β-D-galactopyranoside (Compound 7)

[0077] 1.2 Synthesis route of disaccharide glycosyl acceptor (compound 7)

[0078]

[0079] 1.3 Specific experimental steps:

[0080] Preparation of compound 9

[0081] Compound 10 (2 g, 5.3 mmol) was dissolved in 18 mL of N,N-dimethylformamide, 2,6-lutidine (1.9 mL, 15.9 mmol) was added under argon protection, and then stirred at -50 ° C for 20 min, TBSOTf (tert-butyldimethylsilyl trifluoromethanesulfonate) (2.4 mL, 10.6 mmol) was added, and stirred for 0.5 h. TLC detected that the reaction of the raw materials was complete, and a saturated sodium bicarbonate solution was added to quench the reaction. After dilution with 200 mL of dichloromethane, the filtrate was washed with a saturated sodium bicarbonate solution and sodium chloride in turn, dried over anhydrous sodium sulfate, filtered and concentrated, and separated by silica gel column chromatography (petroleum ether: ethyl acetate = 6:1) to obtain a white solid compound 9 (2.3 g, 88%).

[0082] Preparation of compound 11

[0083] Add the reaction flask Molecular sieves, vacuum baking bottle, cool to room temperature and then pass argon, add compound 8 (3.8g, 8.8mmol, glycosyl donor) and compound 9 (3.9g, 8.0mmol, glycosyl acceptor) in sequence, dissolve with 80mL freshly distilled dichloromethane, stir at room temperature for 5 minutes, then cool the reaction solution to 0°C, add TMSOTf (163μL, 0.9mmol), react at this temperature for 10 minutes, and TLC detects that the reaction of the raw materials is complete. The reaction is quenched with triethylamine, diluted with dichloromethane, and the molecular sieves are filtered out through a diatomaceous earth pad. The filtrate is washed with saturated sodium bicarbonate solution and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, filtered and concentrated, and separated by silica gel column chromatography (dichloromethane: methanol = 20:1) to obtain white solid compound 11 (5.7g, 95%). 1 HNMR (400MHz, CDCl 3 )δ7.53(dd,J=7.5,2.2Hz,2H,ArH),7.39–7.33(m,3H,ArH),7.02–6.98(m,2H,ArH),6.84–6.80(m,2H,ArH),5.50(s,1H ,PhCH),5.39(dd,J=3.4,1.7Hz,1H,2a-H),5.27(d,J=1.6Hz,1H,1b-H),5.21(dd,J=10.1,3.5Hz,1H,3a-H),5.05(t,J=1 0.1Hz,1H,4a-H),4.90(d,J=7.9Hz,1H,1a-H),4.46–4.38(m,1H,5a-H),4.34(dd,J=12.3,1.4Hz,1H,6b-H),4.24(dd,J =9.4,7.9Hz,1H,2b-H),4.07(td,J=5.3,4.7,1.8Hz,2H,6b-H,4b-H),3.96(dd,J=9.4,3.6Hz,1H,3b-H),3.78(s,3H,OCH 3 ),3.50(s,1H,5b-H),2.11(s,3H,COCH 3 ),2.00(s,3H,COCH 3 ),1.96(s,3H,COCH 3 ),1.20(d,J=6.3Hz,3H,6a-CH 3 ),0.86(s,9H,tert-Butyl),0.11(d,J=7.2Hz,6H,SiMe). 13 C NMR (100 MHz, CDCl 3)δ175.0,174.8,174.6,160.1,156.0,142.5,133.6,132.8,130.9,123.3,119.3,105.5,105.2,103.1,103.0,81.1 ,79.9,79.0,75.7,74.4,74.1,73.9,71.3,71.2,60.4,30.4,25.8,25.84,25.62,22.8,22.0,0.7.HRMS(ESI)Calcd for C 38 H 52 NaO 14 Si + [M+Na] + :783.3019,found:783.3049.

[0084] Preparation of compound 12

[0085] Compound 11 (11 g, 14.5 mmol) was placed in a round-bottom flask, 72.5 mL of TBAF (1 M concentration in THF solution, 72.5 mmol) was added, and the mixture was stirred at room temperature for 1 h. TLC showed that the reaction of the raw material was complete. The reaction system was then diluted with ethyl acetate, washed with saturated ammonium chloride solution and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The crude product was then dissolved in 200 mL of 80% acetic acid, stirred at 90 ° C for 1 h, TLC showed that the reaction of the raw material was complete, cooled, concentrated, and separated by column chromatography (ethyl acetate: methanol = 10: 1) to obtain compound 12 (7.2 g, 89%). 1 H NMR (400 MHz, CDCl 3 )δ7.01–6.95(m,2H,ArH),6.87–6.80(m,2H,ArH),5.37(dd,J=3.4,1.8Hz,1H,2a-H),5.32(d,J=1.8Hz,1H,1a-H),5.22(dd,J=10.2,3.4Hz,1H,3a-H ),5.08(t,J=10.0Hz,1H,4a-H),4.87(d,J=7.7Hz,1H,1b-H),4.27(dt,J=9 .8,6.2Hz,1H,5a-H),4.04–3.80(m,4H,2b-H,3b-H,6b-H),3.78(s,3H,OCH 3 ),3.60(t,J=5.3Hz,1H,5b-H),3.52–3.42(m,2H,4b-H),2.66(s,1H),2.14(s,3H,COCH 3 ),2.02(s,3H,COCH 3),1.98(s,3H,COCH 3 ),1.21(d,J=6.2Hz,3H,6a-CH 3 ). 13 C NMR (100 MHz, CDCl 3 )δ170.7,170.5,170.0,155.2,151.0,117.7,114.6,100.3,98.0,76.1,74.3,70. 9,69.7,69.5,69.3,66.5,61.3,55.6,20.8,20.73,20.70,17.3.HRMS(ESI)Calcd for C 25 H 34 NaO 14 + [M+Na] + :581.1841,found:581.1893.

[0086] Preparation of compound 7

[0087] Add the reaction flask Molecular sieves, vacuum the flask, cool to room temperature and pass argon, add compound 12 (7.1g, 12.7mmol), dissolve it with 225mL of a mixed solution of dichloromethane: N, N-dimethylformamide = 3:1, then add benzoyl cyanide (3.7g, 27.9mmol), stir at room temperature for 5 minutes, then put the reaction solution into -78℃, add 4-dimethylaminopyridine (379mg, 3.1mmol), react at this temperature for 5h, and TLC detects that the raw material reaction is complete. Ammonium chloride and methanol are added in sequence to quench the reaction, and then the molecular sieve is filtered out through a diatomaceous earth pad. The filtrate is washed with dichloromethane and concentrated, and separated by silica gel column chromatography (petroleum ether: ethyl acetate = 1:3) to obtain a white solid compound 7 (7.8g, 80%). 1 H NMR (400 MHz, CDCl 3)δ8.13–8.08(m,2H,ArH),8.05–8.00(m,2H,ArH),7.59–7.53(m,2H,ArH),7.43(td,J=7.7,1.4Hz,4H,ArH),7.06–7.01(m,2H,ArH),6.75–6.69(m,2H,ArH),5.66–5.63(m,1H,4b-H),5.39(dd,J=3.5,1.8Hz,1H,2a-H),5.32(d,J=1.8Hz,1H,1a-H),5.24(dd,J=10.1,3.4Hz,1H,3a-H),5.10(t,J=10.0Hz,1H,4a-H),4.99(d,J=6.8Hz,1H,1b-H),4.54–4.44(m,2H,6b-H),4.40(dt,J=9.9,6.2Hz,1H,5a-H),4.22–4.11(m,3H,2b-H,3b-H,5b-H),3.74(s,3H,OCH 3 ),2.06(s,3H,COCH 3 ),2.03(s,3H,COCH 3 ),1.96(s,3H,COCH 3 ),1.29(d,J=6.2Hz,3H,6a-CH 3 ). 13 C NMR(100MHz,CDCl 3 )δ170.4,170.2,170.0,166.8,166.0,155.4,151.1,130.1,129.8,128.5,128.4,118.1,114.6,100.5,98.3,75.9,73.6,71.5,71.0,70.9,69.6,69.4,66.6,62.7,55.6,20.84,20.82,20.75,17.4.HRMS(ESI)Calcd for C 39 H 42 NaO 16 + [M+Na] + :789.2366,found:789.2395.

[0088] Example 2:

[0089] 2.1 Chemical Synthesis 2-O-(2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl)-3-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-4,6-di-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate (Compound 4)

[0090] 2.2 Synthesis route of compound 4

[0091]

[0092] 2.3 Specific experimental steps:

[0093] Preparation of compound 13

[0094] Add the reaction flask Molecular sieves, vacuum-baked bottle, cooled to room temperature and then purged with argon, compound 6 (384 mg, 519 μmol, glycosyl donor) and compound 7 (766 mg, 415 μmol, glycosyl acceptor) were added in sequence, dissolved with 2.6 mL of freshly distilled dichloromethane, stirred at room temperature for 5 minutes, then the reaction solution was cooled to 0 ° C, TMSOTf (9.4 μL, 51.9 μmol) was added, and the reaction was carried out at this temperature for 40 minutes. TLC detected that the reaction of the raw material was complete. The reaction was quenched with triethylamine, diluted with dichloromethane, and the molecular sieve was filtered out through a diatomaceous earth pad. The filtrate was washed with saturated sodium bicarbonate solution and saturated sodium chloride solution in turn, dried over anhydrous sodium sulfate, filtered and concentrated, and separated by silica gel column chromatography (petroleum ether: dichloromethane: ethyl acetate = 6:6:1) to obtain white solid compound 13 (500 mg, 93%). 1 H NMR (400 MHz, CDCl 3)δ8.03(dd,J=14.9,8.0Hz,6H,ArH),7.92(d,J=7.8Hz,2H,ArH),7.75(d,J=7.8Hz,2H ArH),7.67–7.18(m,18H ArH),6.99–6.91(m,2HArH),6.70–6.61(m,2H ArH),6.01(t,J=9.6Hz,1H,3c-H),5.75–5.63(m,2H,,4b-H,4c-H),5.41(dd,J=9.9,7.8Hz,1H,2c-H),5.38–5.35(m,1H,2a-H),5.31(dd,J=10.2,3.5Hz,1H,3a-H),5.27(d,J=7.9Hz,1H,1c-H),5.24(d,J=1.8Hz,1H,1a-H),5.11(t,J=10.0Hz,1H,4a-H),4.75(d,J=7.3Hz,1H,1b-H),4.65(dd,J=12.2,4.9Hz,1H,6c-H),4.56(dd,J=12.2,3.2Hz,1H,6c-H),4.45(qd,J=11.6,6.2Hz,2H,6b-H),4.34–4.16(m,5H,3b-H,2b-H,5c-H,5b-H,5a-H),3.98(dd,J=8.0,4.7Hz,1H),3.71(s,3H,OCH 3 ),2.14(s,3H,COCH 3 ),2.09(s,3H,COCH 3 ),2.05(s,2H,COCH 3 ),1.13(d,J=6.2Hz,3H,6a-CH 3 ). 13 C NMR(100MHz,CDCl 3 )δ170.3,170.1,170.0,166.0,165.9,165.7,165.5,165.1,164.7,155.4,151.0,118.1,114.4,100.6,99.4,97.8,75.5,72.54,72.51,71.8,70.9,70.0,69.9,69.8,69.0,67.0,62.9,62.7,55.6,20.9,17.3.HRMS(ESI)Calcd for C 73 H 68 NaO 25 + [M+Na] +:1367.3942,found:1367.3985.

[0095] Preparation of compound 4

[0096] Compound 13 (1.1 g, 0.8 mmol) was dissolved in 80 mL of a mixed solution of acetonitrile: water = 4:1, and ammonium cerium nitrate (2.2 g, 4.1 mmol) was added at 0°C, and the mixture was reacted for 15 min at this temperature. After TLC detection, the reaction of the raw material was completed, and a saturated sodium bicarbonate solution was added to quench the reaction, and then diluted with ethyl acetate, and the precipitate was filtered out through a diatomaceous earth pad. The organic phase was washed with saturated sodium bicarbonate and saturated sodium chloride solutions in turn, dried over anhydrous sodium sulfate, filtered and concentrated. The white solid compound S1 was obtained by separation by silica gel column chromatography (petroleum ether: ethyl acetate = 1:1). The crudely purified compound S1 (1.6 g, 1.3 mmol) in the previous step was dissolved in freshly dichloromethane. In an ice-water bath, trichloroacetonitrile (391 μL, 3.9 mmol) and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) (39 μL, 260 μmol) were added in sequence. The temperature was naturally raised and the reaction was carried out for 5 h. After TLC detection, the reaction of the raw materials was complete. The solvent was removed by rotary evaporation and separated by silica gel column chromatography (petroleum ether: ethyl acetate = 1:1) to obtain a white foamy solid compound 4 (1.4 g, 78%). 1 H NMR (400 MHz, CDCl 3 )δ8.69(s,1H,NHCCl 3 ),8.05–7.93(m,6H,ArH),7.94–7.88(m,2H,ArH),7.76–7.71(m,2H ArH),7.56–7.29(m,11H ArH),7.21(td,J=7.8,2.0Hz,4HArH),6.51(d,J=3.7Hz,1H,1b-H),6.03–5.95(m,2H,4b-H,3c-H),5.70(t ,J=9.7Hz,1H,4c-H),5.47–5.43(t,1H,2c-H),5.39–5.34(m,2H,1c-H,2a-H),5.23(dd,J=10.2,3.1Hz,1H ,3a-H),5.07(t,J=10.0Hz,1H,4a-H),4.88(d,J=1.8Hz,1H,1a-H),4.63–4.52(m,4H,5c-H,3b-H,6c-H),4 .47–4.33(m,3H,5b-H,6b-H),4.26(dd,J=9.9,3.7Hz,1H,2b-H),3.96–3.87(m,1H,5a-H),2.12(s,3H,COCH 3 ),2.06(s,3H,COCH3 ),2.02(s,3H,COCH 3 ),1.15(d,J=6.3Hz,3H,6a-CH 3 ). 13 CNMR (100MHz, CDCl 3 )δ170.1,169.8,169.5,166.2,166.0,165.9,165.4,165.3,165.1,164.6,160.8,133.3,133.2,133.1 3,133.07,133.03,132.96,132.9,129.93,129.86,129.8,129.73,129.66,129.64,129.58,129.5,12 9.1,129.04,129.03,128.3,128.15,128.10,99.8,95.0,90.8,72.7,72.4,72.3,71.7,70.5,70.1,69 .9,69.6,69.4,69.1,67.7,63.0,62.7,60.3,21.0,20.93,20.85,20.82,20.77,17.4.HRMS(ESI)Calcd for C 68 H 62 Cl 3 NNaO 24 + [M+Na] + :1404.2620,found:1404.2660.

[0097] Embodiment 3:

[0098] 3.1 Chemical synthesis of solanine (compound 1)

[0099] 3.2 Synthesis route of solanine (compound 1)

[0100]

[0101] 3.3 Specific experimental steps:

[0102] Preparation of compound 16

[0103] Add the reaction flask Molecular sieves, vacuum-baked bottle, cooled to room temperature and then purged with argon, compound 4 (50 mg, 36.2 μmol, glycosyl donor) and compound 3 (19 mg, 43.4 μmol, glycosyl acceptor) were added in sequence, dissolved with 724 μL of a mixed solution of dichloromethane: trimethylacetonitrile = 5:1, stirred at room temperature for 5 minutes, then the reaction solution was placed at -50 °C, gold trichloride (1.1 mg, 3.62 μmol) was added, and the reaction was carried out at this temperature for 10 minutes. TLC detected that the reaction of the raw material was complete. The reaction was quenched with triethylamine, the molecular sieve was filtered out through a diatomaceous earth pad, and separated by silica gel column chromatography (petroleum ether: ethyl acetate = 1:1) to obtain a white solid compound 16 (48 mg, 81%). 1 H NMR (400 MHz, CDCl 3 )δ8.06–7.95(m,7H,ArH),7.93–7.86(m,2H,ArH),7.77–7.70(m,2H,ArH),7.64–7.58(m,2 H,ArH),7.58–7.18(m,19H,ArH),5.96(t,J=9.6Hz,1H,3c-H),5.70–5.60(m,2H,4c-H,4b-H ),5.40–5.25(m,4H,3a-H,2a-H,2c-H,5b-H),5.21–5.14(m,2H,1a-H,1c-H),5.08(t,J=9. 9Hz,1H,4a-H),4.75(ddd,J=10.1,7.8,5.7Hz,1H,6c-H),4.60(dd,J=12.2,4.7Hz,1H,6c-H ),4.54–4.47(m,1H,6b-H),4.47–4.31(m,3H,5a-H,6b-H,1b-H),4.19(ddd,J=21.5,8.8,3 .7Hz,2H,5c-H,3b-H),3.98(dd,J=9.4,7.8Hz,1H,2b-H),3.87(dd,J=7.9,5.3Hz,1H,5b-H) ,3.52(tt,J=11.1,4.6Hz,1H),3.23(dd,J=12.0,5.6Hz,1H),3.10(dd,J=12.0,7.0Hz,1H), 2.48(d,J=10.1Hz,1H),2.45–2.37(m,1H),2.25(dd,J=28.1,13.9Hz,1H),2.13(s,3H,COCH 3 ),2.04(s,3H,COCH 3 ),2.05(s,3H,COCH 3),1.92–1.68(m,2H),1.60(d,J=7.0Hz,5H),1.51–1.38(m,2H),1.36–1.21(m,5H),1.15(d,J=6.2Hz,3H,6a-CH 3 ),0.97(d,J=6.7Hz,6H),0.89(q,J=7.1,5.5Hz,3H),0.68(s,3H). 13 C NMR (100 MHz, CDCl 3 )δ170.3,170.2,170.0,166.0,165.98,165.96,165.5,165.1,164.7,151.2,140.3,133.3,133.1,133.03,133.00,132.91,132.88,130 .1,130.0,129.9,129.88,129.80,129.77,129.71,129.68,129.6,129.1,129.0,128.9,128.4,128.34,128.29,128.2,128.1,121.8,1 04.0,100.0,99.3,97.2,84.3,79.7,74.0,72.5,71.4,71.1,70.1,69.9,69.7,69.0,66.5,64.2,62.7,57.6,55.00,50.01,43.3,39.5, 38.4,37.0,36.8,34.1,33.0,32.2,31.5,31.2,29.71,29.65,23.2,20.95,20.90,20.86,19.3,17.6,17.3,14.0,11.7.HRMS(ESI)Calcd for C 93 H 102 N 3 O 25 + [M+H] + :1661.6831,found:1661.6881.

[0104] Preparation of compound 17

[0105] Compound 16 (110 mg, 66.3 μmol) was dissolved in 3 mL of dry acetonitrile, sodium iodide (20 mg, 133 μmol) was added, and the mixture was stirred at room temperature for 30 min, followed by dropwise addition of TMSCl (18 μL TMSCl dissolved in 150 μL acetonitrile, 142.5 μmol). The mixture was reacted at this temperature for 30 min, and the reaction was complete after TLC detection. A 10% sodium thiosulfate solution was added to quench the mixture, and the pH of the reaction solution was adjusted to 10 with a 5% sodium hydroxide solution. After stirring for 1 h, the mixture was washed with dichloromethane and a saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated, and separated by silica gel column chromatography (petroleum ether: ethyl acetate: triethylamine = 1:2:0.03) to obtain a white foam solid compound 17 (90.4 mg, 84%). 1 H NMR (400 MHz, CDCl 3 )δ8.08–7.94(m,6H,ArH),7.90(d,J=7.8Hz,2H,ArH),7.73(d,J=7.8Hz,2H,A rH),7.61(d,J=7.7Hz,2H,ArH),7.58–7.25(m,17H,ArH),7.21(t,J=7.7Hz,2 H, ArH), 5.96 (t, J = 9.6Hz, 1H, 3c-H), 5.68–5.61 (m, 2H, 4c-H, 4b-H), 5.38–5. 27(m,4H,3a-H,2a-H,2c-H,5b-H),5.21–5.15(m,2H,1a-H,1c-H),5.08(t,J= 9.8Hz,1H,4a-H),4.61(dd,J=12.2,4.8Hz,1H,6c-H),4.55–4.25(m,5H,6c-H ,6b-H,5a-H,6b-H,1b-H),4.25–4.14(m,2H,5c-H,3b-H),3.98(t,J=8.6Hz,1 H,2b-H),3.86(dd,J=7.7,5.3Hz,1H,5b-H),3.51(tt,J=10.8,4.6Hz,1H),2. 71–2.56(m,2H),2.44–2.37(m,1H),2.27(t,J=12.2Hz,1H),2.13(s,3H,COCH 3 ),2.06(s,3H,COCH 3 ),2.04(s,3H,COCH 3 ),2.02–1.94(m,2H),1.89(q,J=7.2Hz,2H),1.82–1.39(m,11H),1.32–1.22(m,3H),1.15(d,J=6.2Hz,3H,6a-CH 3),0.96(d,J=6.7Hz,5H),0.85(d,J=6.2Hz,3H),0.81(s,3H). 13 C NMR (100 MHz, CDCl 3 )δ170.2,170.1,169.9,166.0,165.9,165.5,165.1,164.6,140.3,133.3,133.0,132.8,130.1,129.9,129.8,1 29.7,129.6,129.2,129.0,128.9,128.38,128.36,128.3,128.13,128.07,121.8,100.1,99.4,98.3,97.2,79. 7,74.1,72.6,71.4,71.2,70.2,69.9,69.8,69.0,66.5,62.8,62.7,60.4,56.5,50.1,47.7,41.3,40.5,39.9,3 8.4,37.0,36.8,34.1,32.2,31.4,30.3,29.7,20.9,20.8,19.3,19.2,17.3,16.4,15.3,14.2.HRMS(ESI)Calcd for C 93 H 104 NO 25 + [M+H] + :1635.6926,found:1635.6963.

[0106] Preparation of compound 1

[0107] Compound 17 was dissolved in a mixed solution of dichloromethane:methanol=1:4, 1M sodium hydroxide was added to adjust the pH to 12, and the mixture was refluxed and stirred at 70°C for 4 h. TLC detected that the reaction of the raw material was complete, and the solvent was removed by rotary evaporation. The mixture was separated by silica gel column chromatography (dichloromethane:methanol containing 8% water:triethylamine=3:1:0.01) to obtain white solid compound 1 (64 mg, 91%). 1 H NMR (400 MHz, Pyridine-d 5)δ6.25(d,J=1.4Hz,1H),5.28(d,J=5.0Hz,1H),5.15(d,J=7.7Hz,1H),4.89(d,J=7.8Hz,2H),4.86(dd,J=3.2,1.7Hz,1H),4.77(d,J=3 .1Hz,1H),4.66(dd,J=9.6,7.8Hz,1H),4.56(dd,J=9.3,3.4Hz,1H),4.45–4.37(m,2H),4.34(dd,J=11.2,6.5Hz,1H),4.30–4.23(m,3H ),4.20(dd,J=11.3,5.1Hz,1H),4.17–4.10(m,2H),3.97(t,J=6.1Hz,1H),3.90(q,J=7.3,5.8Hz,3H),2.80–2.66(m,4H),2.12–1.97(m ,2H),1.92(q,J=9.2,8.1Hz,1H),1.88–1.78(m,1H),1.78–1.13(m,17H),1.11–0.97(m,8H),0.96–0.80(m,6H),0.77(d,J=4.5Hz,3H). 13 C NMR (150 MHz, Pyridine-d 5 )δ140.8,121.6,105.8,102.2,100.3,98.3,84.7,79.2,78.4,78.3,7 7.4,76.4,75.0,74.9,74.1,72.8,72.5,71.5,70.4,69.4,63.3,62.52 ,62.47,56.5,50.2,47.7,41.6,40.6,39.9,38.7,37.4,37.1,34.4,3 2.5,32.2,31.6,31.2,30.7,30.0,21.0,19.5,19.3,18.5,16.4,15.6.

[0108] Embodiment 4:

[0109] 4.1 Chemical synthesis of solanine derivatives (compound 2)

[0110] 4.2 Synthesis route of compound 2

[0111]

[0112] 4.3 Specific experimental steps:

[0113] Preparation of compound 15

[0114] Add the reaction flask Molecular sieves, vacuum-baked bottle, cooled to room temperature and then purged with argon, compound 4 (50 mg, 36.2 μmol, glycosyl donor) and compound 5 (19 mg, 43.4 μmol, glycosyl acceptor) were added in sequence, dissolved with 3.6 mL of dichloromethane: trimethylacetonitrile = 5:1 mixed solution, stirred at room temperature for 5 minutes, then the reaction solution was placed at -50 ° C, gold trichloride (1.1 mg, 3.62 μmol) was added, and the reaction was carried out at this temperature for 10 minutes. TLC detected that the reaction of the raw material was complete. The reaction was quenched with triethylamine, the molecular sieve was filtered out through a diatomaceous earth pad, and separated by silica gel column chromatography (petroleum ether: ethyl acetate = 3:1) to obtain a semi-solid compound 15 (49.6 mg, 84%). 1 H NMR (400 MHz, CDCl 3 )δ8.04–7.95(m,6H,ArH),7.90(d,J=7.9Hz,2H,ArH),7.73(d,J=7.7Hz,2H,ArH),7.61(d,J=7.7Hz,2H,ArH),7.56–7.18(m,15H,ArH),5.96(t,J=9. 6Hz,1H,3c-H),5.70–5.62(m,2H,4c-H,4b-H),5.40–5.27(m,5H,2c-H,2a -H,3a-H),5.22–5.15(m,2H,1c-H,1a-H),5.08(t,J=9.7Hz,1H,4a-H),4.6 1(dd,J=12.2,4.8Hz,1H,6c-H),4.54–4.30(m,6H,6c'-H,5a-H,1b-H,5b- H,6b-H,6b'-H),4.25–4.09(m,2H,5c-H),3.98(t,J=8.6Hz,1H,3b-H),3.8 6(dd,J=7.8,5.2Hz,1H,2b-H),3.50(ddd,J=15.6,10.8,5.5Hz,2H),3.38 (t,J=10.9Hz,1H),2.46–2.38(m,1H),2.32–2.23(m,1H),2.13(s,3H,COCH 3 ),2.05(d,J=5.8Hz,6H,COCH 3 ),2.03–1.93(m,1H),1.92–1.70(m,4H),1.69–1.60(m,6H),1.55–1.36(m,3H),1.35–1.22(m,4H),1.15(d,J=6.2Hz,3H,6a-CH 3 ),1.00–0.95(m,6H),0.94–0.83(m,2H),0.79(d,J=6.4Hz,6H).13 C NMR (150 MHz, CDCl 3 )δ169.2,169.1,169.0,165.00,164.98,164.9,164.5,164.1,163.6,139.3,132.3,132.02,132.00,131.97,131.9,131.8,129.1,12 8.9,128.8,128.74,128.69,128.65,128.63,128.56,128.1,127.93,127.87,127.4,127.3,127.13,127.08,120.8,108.3,99.0,98. 3,96.2,79.8,78.8,76.5,73.0,71.5,70.4,70.1,69.1,68.9,68.7,68.0,65.8,65.5,61.6,61.1,55.5,49.0,40.6,39.2,38.7,37.4 ,35.9,35.8,35.6,31.1,30.9,30.8,30.4,29.3,28.7,28.6,27.8,19.9,19.81,19.78,18.2,16.3,16.1,15.3,13.5.HRMS(ESI)Calcd forC 93 H 103 O 26 + [M+H] + :1636.6766, found:1636.6751; C 93 H 102 NaO 26 + [M+Na] + :1658.6586, found:1636.6586; C 93 H 106 NO 26 + [M+NH 4 ] + :1653.7032,found:1653.7023.

[0115] Preparation of compound 2

[0116] Compound 15 was dissolved in a mixed solution of dichloromethane:methanol = 1:2, 1M sodium hydroxide was added to adjust the pH to 9-10, and the mixture was stirred at room temperature for 4 h. TLC detected that the reaction of the raw material was complete, and the solvent was removed by rotary evaporation. The mixture was separated by silica gel column chromatography (dichloromethane:methanol = 2:1) to obtain white solid compound 2 (24.9 mg, 83%). 1H NMR (400 MHz, Pyridine-d 5 )δ6.27(s,1H),5.32(d,J=5.1Hz,1H),5.20(d,J=7.7Hz,1H),5.05–4.77(m,4H),4.72–4.52(m,3H),4.47(dd, J=11.7,2.4Hz,1H),4.32(tdd,J=16.6,11.1,5.1Hz,6H),4.20(t,J=9.1Hz,1H),4.08–3.85(m,5H),3.63–3.5 5(m,1H),3.51(t,J=10.0Hz,1H),2.84–2.57(m,3H),2.08(ddd,J=25.4,11.7,6.4Hz,2H),2.00–1.77(m,3H), 1.76–1.36(m,12H),1.26(q,J=7.7,7.3Hz,2H),1.19–1.00(m,6H),0.99–0.78(m,5H),0.71(d,J=5.1Hz,4H). 13 C NMR (100 MHz, Pyridine-d 5 )δ140.7,121.6,109.1,105.7,101.9,100.2,84.7,81.0,78.24,78.20,77.4,76.3,75.1,74.8,73.8,72.7,72.4,71.4,70.2,69.2,66.7, 62.7,62.4,62.3,56.5,50.1,41.8,40.3,39.7,38.6,37.3,37.0,32.1,31.5,30.4,30.0,29.8,29.1,20.9,19.2,18.4,17.2,16.2,14.9.

[0117] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing a compound of formula I, characterized in that: Wherein, X is -NH- or -O-; The method comprises the steps of glycosidation reaction of compound 4 and compound 3 or 5 under the coordinated catalysis of gold (III) ions and nitrile compounds to obtain compound 16 or 15; and a deprotection step; Among them, the structures of compounds 3, 4, 5, 15 and 16 are shown below:

2. The method according to claim 1, characterized in that When compound 4 and compound 3 are subjected to glycosidation reaction, the method further comprises: before deprotection, a step of reducing the azide group in compound 16 to an amino group.

3. The method according to claim 1, characterized in that The nitrile compound is trimethylacetonitrile.

4. The method according to claim 1, characterized in that The preparation method of compound 4 comprises the following steps: Compound 6 and compound 7 are subjected to glycosylation reaction to obtain compound 13; Converting compound 13 into compound S1; Converting compound S1 into compound 4; Among them, the structures of compounds 6, 7, 13 and S1 are shown below:

5. The method according to claim 4, characterized in that The conversion of compound 13 into compound S1 comprises the following steps: Compound 13 is dissolved in a mixed solution of acetonitrile and water, and ammonium cerium nitrate is added at low temperature to react. After the reaction is completed, compound S1 is obtained; Preferably, the low temperature is -2 to 2°C.

6. The method according to claim 4, characterized in that The conversion of compound S1 into compound 4 comprises the following steps: Compound S1 was dissolved in an organic solvent, trichloroacetonitrile and 1,8-diazabicyclo[5.4.0]undec-7-ene were added in sequence under an ice-water bath, and the temperature was naturally raised to react. After the reaction was completed, compound 4 was obtained; Preferably, the organic solvent comprises dichloromethane.

7. The method according to claim 4, characterized in that The preparation method of compound 7 comprises the following steps: Converting compound 10 into compound 9; Compound 9 is subjected to glycosylation reaction with compound 8 to obtain compound 11; Converting compound 11 into compound 12; An acylating agent was used to selectively protect the 4- and 6-hydroxyl groups in compound 12 to obtain compound 7; Among them, the structures of compounds 8, 9, 10, 11 and 12 are shown below:

8. The method according to claim 7, characterized in that The conversion of compound 10 into compound 9 comprises the following steps: Compound 10 is dissolved in an organic solvent, 2,6-lutidine is added under a protective atmosphere, and after stirring at low temperature, tert-butyldimethylsilyl trifluoromethanesulfonate is added, and the reaction is stirred. After the reaction is completed, compound 9 is obtained; Preferably, the organic solvent comprises N,N-dimethylformamide; Preferably, the low temperature is -55 to -45°C.

9. The method according to claim 7, characterized in that The conversion of compound 11 into compound 12 represented by the formula comprises the following steps: Add tetrabutylammonium fluoride solution to compound 11, stir at room temperature for reaction, and complete the reaction to obtain compound 12; Preferably, in the tetrabutylammonium fluoride solution, the solvent is tetrahydrofuran.

10. The method according to claim 7, characterized in that The acylating agent is benzoyl chloride; Compound 12 was reacted at low temperature in one pot using the cyanide effect of benzoyl cyanide to obtain compound 7 with selective protection at the 4 and 6 positions; Preferably, the low temperature is -80 to -75°C.

Citation Information

Patent Citations

  • Method for efficiently synthesizing solamargine

    CN102731609A

  • Synthetic method of spirosolane glycoalkaloids

    CN103193858A